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Abstract 
Secretory and anti-inflammatory actions of some gastro-intestinal 
hormones in salivary glands 
 
Hülya Çevik Aras 
Institute of Neuroscience and Physiology, Section of Pharmacology, The Sahlgrenska Academy, 
University of Gothenburg, Box 431, SE-405 30, Gothenburg, Sweden 
 
Textbooks generally state that the secretory activity of salivary glands is solely regulated by 
nerves. This view is challenged in the present Thesis, using the parotid gland of the 
anaesthetized rat as experimental in vivo model.  By changing focus from secretion of fluid to 
secretion of protein and of acinar amylase a secretory role was found not only for gastrin and 
cholecystokinin but also for the non-traditional gastro-intestinal hormone melatonin. Neither 
intravenous infusion of the hormone-analogues pentagastrin and desulfated cholecystokinin-8 
nor of melatonin evoked any overt fluid secretion from the duct-cannulated gland. However, a 
subsequent intravenous wash-out injection of the secretagogue methacholine revealed 
protein/amylase secretion in response to the infusion of the hormone/hormone-analogues. The 
hormone/hormone-analogues exerted their effect directly on the gland cells: it persisted in the 
presence of α- and β-adrenoceptor antagonists, after disconnecting the gland from its peripheral 
ganglia and after evisceration. The gland protein synthesis increased to pentagastrin.  
Cholecystokinin(CCK) -A and CCK-B receptor types as well as the melatonin receptors, MT1 and 
MT2, were expressed in the gland. By the use of hormone-receptor antagonists, protein secretion 
was shown to involve mainly the CCK-A receptors and the MT2 receptors, whereas both types of 
cholecystokinin receptors were involved in the protein synthesis. The secretion of 
protein/amylase and the synthesis of protein to the hormone/ hormone-analogues were partially 
dependent on nitric oxide generated by the activity of neuronal type NO-synthase, probably of 
parenchymal origin. Cholecystokinin may occur as a transmitter in the peripheral nervous system 
and, hypothetical, cholecystokinin might belong to the group of parasympathetic non-adrenergic, 
non-cholinergic transmitters that upon stimulation of the parasympathetic auriculo-temporal nerve 
evokes secretion of fluid and, in particular, secretion of protein/amylase. However, the stimulation 
of the parasympathetic innervation, in the presence of cholecystokinin receptor antagonists, gave 
no support for a transmitter role for cholecystokinin in the gland. Lipopolysaccharide injected 
intraductally towards the parotid gland induced inflammation, as shown by neutrophil infiltration 
and increased myeloperoxidase activity in the gland, and mobilization of β-defensins, being a 
part of the oral defense mechanism. Melatonin and cholecystokinin (sulphated CCK-8) 
administered intraperitoneally exerted anti-inflammatory actions in the inflamed gland as judged 
by reduced levels of the elevated activity of myeloperoxidase. The effect of melatonin was non-
receptor mediated, while that of sulphated CCK-8 was partially dependent on CCK-A receptors. 
The inflammatory response involved NO generated from inducible NO-synthase and neuronal 
type of NO-synthase as shown by selective NO-synthase inhibitors, the neuronal type being most 
likely of parenchymal origin, since it was activated also in the chronically denervated gland. In 
conclusion, the secretory activity of salivary glands seems not only to be regulated by a cephalic 
phase of nervous activity but also by a gastric phase and an intestinal phase of endocrine 
activity. Circulating melatonin and cholecystokinin/gastrin may not only influence the secretory 
activity but may also protect the salivary glands from inflammation. The present findings have 
implications for salivary gland dysfunction/dry mouth and its treatment.  
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INTRODUCTION 
 
Saliva exerts digestive and protective functions and further, it is necessary for the 
articulate speech. It is essential for chewing, bolus formation and swallowing. 
Saliva contains enzymes that degrade the food, notable amylase and lipase, and 
these enzymes continue their activity in the stomach at varying length of time. It 
is a solvent for tastants in food and carries them to the taste buds. A mucin-rich 
film of saliva covers and protects the oral structures and promotes the re-
mineralization of the teeth. Bicarbonate and histidine-rich peptides exert saliva’s 
buffering capacity. Saliva protects the oral tissues from noxious agents by its 
antibacterial, antiviral and antifungal activities through lysozymes, peroxidase, 
lactoferrin, immunoglobulin A, histatins, defensins and cathelicidin. A number of 
growth-promoting factors are of importance for wound healing. Furthermore, the 
constant flow of saliva cleanses the oral cavity from food debris and noxious 
agents. The protective functions of saliva are not restricted to just the oral cavity. 
Salivary antimicrobial mechanisms protect the upper respiratory tract from 
infections, acid in the oesophageus is buffered and mechanical and chemical 
damages to the mucosa in the oesophageus and stomach may be repaired by 
growth stimulating factors (Kaplan & Baum, 1993; Tenovou, 1998; Van Nieuw 
Amerongen et al., 2004). Salivation as a part of the thermoregulation in dogs 
(Gregersen, 1931) and rodents (Hainsworth et al., 1967) is a further example, 
that saliva may serve various functions. 
 
In addition to the three paired major salivary glands, hundreds of minor glands 
contribute to the mixed saliva. The contribution of the various glands varies in 
volume as well as in composition. The mucin-rich fluid is mainly produced by the 
minor glands and the sublingual gland, while the large volumes of the watery 
fluid are produced by the parotid and submandibular glands (Sreebny & Broich, 
1988). 
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In the salivary glands, the activity of calcium dependent ion channels account for 
fluid and electrolyte secretion. Briefly, upon stimulation, cytoplasmatic Ca 2+ rises 
as a consequence of a release from internal stores and influx from the 
interstitium. Increased levels of intracellular Ca 2+ activates basolateral K+ - and 
apical Cl– -channels to open and allow the two electrolytes to move down their 
concentration gradients to the extracellular compartment. The accumulation of 
Cl- in the acinar lumen will drag Na+ by a paracellular route to the lumen. The 
luminal increase of NaCl creates an osmotic gradient that may cause a rapid 
movement of large volumes of water into the lumen provided the gland blood 
flow is adequately adapted to the increased demands (Poulsen, 1998). 
 
Proteomic analysis of saliva has so far demonstrated several hundreds of 
proteins/peptides (Hu et al., 2005). Multiple pathways exist for the secretion of 
proteins, the main distinction being the regulated granular secretion and the 
constitutive non-granular (vesicle) secretion (Castle & Castle, 1998). Along the 
regulated pathway, proteins are condensed, after leaving the Golgi apparatus, in 
maturing storage granules and transported to the apical part of the cell and 
released from large dense core granules by exocytosis in response to 
stimulation. The time from synthesis to exocytosis is several hours. The 
intracellular messenger cyclic AMP is usually associated with the exocytosis. The 
constitutive pathway is thought to represent the fundamental mechanism for 
secretion occurring in all cells. Along this pathway, the proteins, after leaving the 
Golgi apparatus, by-pass the granular storage stage and move towards both the 
apical and basolateral membranes from where they are continuously released. A 
vesicular release in response to stimulation is superimposed upon this 
continuous basal constitutive secretion. In salivary glands, biochemical findings 
show synthesized proteins to be released as fast as they are synthesized 
(Proctor, 1998). 
 
During the passage of saliva through the duct system, the composition of saliva 
is modified, while the volume remains unchanged. The uptake of sodium ions 
and the secretion of potassium ions are well-known phenomena (Poulsen, 1998). 
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The unstimulated constitutive secretion of kallikrein into the ductule lumen is a 
further example (Garrett et al., 1996). 
 During the night and at rest, a small spontaneous secretion from the human 
minor glands dominates, while in response to a meal the major glands are 
stimulated to secrete by intense nervous activity. A number of reflexes, 
preferentially originating from the mouth, are elicited by taste, chewing, dryness 
and pain but also by smell and by the distension of the esophagus and the 
stomach and by acid in the oesophageus (Hector & Linden, 1999). Moreover, 
nausea and vomiting are well-known phenomena inducing salivation by both 
peripheral and central mechanisms. Fever and stress are examples of inhibitory 
influences on the outflow of impulses from higher brain centers of salivatory 
nuclei. The efferent part of the reflex arch consists of the autonomic 
parasympathetic and sympathetic nerves (Garrett, 1988). 
 
Whereas the secretory elements of all glands are thought to be supplied with a 
parasympathetic innervation, the sympathetic secretory innervation may vary; the 
minor human glands as well as the rat sublingual gland are examples of glands 
lacking a sympathetic nerve supply of their acinar cells. Parasympathetic 
nervous activity may produce large volumes of saliva, whereas sympathetic 
nervous activity produces small volumes of saliva. Both nerves cause secretion 
of large amount of proteins. Since the volume of sympathetic saliva is small, 
sympathetic saliva is usually characterized as protein rich, while parasympathetic 
saliva, due to the large volume, is characterized as protein poor. Under 
physiological conditions, sympathetic activity is considered to occur in a 
background of on-going parasympathetic activity. Combined parasympathetic 
and sympathetic activity interact synergistically to enhance both the secretion of 
fluid and the secretion of protein (Emmelin, 1979; Garrett, 1988). In contrast to 
the positive interactions with respect to the secretion of saliva, the two divisions 
of the autonomic nervous system have opposite effects with respect to the 
regulation of the blood flow through the glands: parasympathetic activity 
increases the flow and sympathetic activity reduces the flow. However, the 
sympathetic vasoconstrictor nerve fibers are separate from the sympathetic 
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secretomotor nerve fibers and are not activated during reflex secretion. In case 
of a dramatic fall in blood pressure, e.g. as a consequence of bleeding, the 
vasoconstrictor fibers are activated (Emmelin, 1967; Edwards, 1998). 
 
The classical neurotransmitters released from the peripheral postganglionic 
parasympathetic and sympathetic nerve endings are acetylcholine and 
noradrenaline, respectively, and the acinar cells are supplied with muscarinic 
receptors of various subtypes as well as of α1- and β1-adrenergic receptors. 
Apart from being exposed to acetylcholine and noradrenaline and, in addition to 
circulating catecholamines, a number of so called non-adrenergic, non-
cholinergic co-transmitters stimulate the acinar cells. Some of these transmitters 
cause a large volume of secretion such as the tachykinins, while others cause 
just a small flow or no overt fluid secretion at all but add proteins to the saliva; 
parasympathetic vasoactive intestinal peptide, calcitonin gene related peptide 
and neuropeptide Y are examples of the latter. Interestingly, the various 
neuropeptides may interact synergistically with each other but also with the 
classical transmitters (Ekström, 1999). Though the parasympathetic nerves of 
the salivary glands contain the nitric oxide (NO) forming enzyme NO-synthase, 
the transmitter role of nitric oxide of parasympathetic origin is unclear. No doubt 
NO is involved in protein secretion, protein synthesis and mitotic activity but this 
is due to the activity of NO-synthase of non-nervous, parenchymal, origin rather 
than of nervous origin (Sayardoust & Ekström, 2003, 2006; Ekström et al., 2004). 
 
Nerves do not only exert short-term influences on the glands, such as on the 
secretion of fluid and proteins, the contraction of the myoepithelial cells and the 
blood flow but also exert long-term influences on the receptor sensitivity to 
agonists, the synthesis of proteins and the gland size (Emmelin, 1967). 
 
Hormones do also take part in the long-term regulation of salivary glands. The 
increased frequency of dry mouth in post-menopausal women is usually 
associated with the decrease in oestrogen production (Eliasson et al., 2003; 
Meurman et al., 2009). In rodents, hypophysectomy, thyroidectomy, 
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gonadectomy, adrenalectomy and experimental diabetes cause glandular 
atrophy, change in saliva composition and volume of saliva secreted (Shafer & 
Muhler, 1953; Ohlin, 1965; Takeuchi, 1977; Johnson, 1988; Anderson, 1994; 
Mahay, 2004). 
 
In contrast, hormones are, on the whole, not thought to play any role in the short-
term regulation of salivary glandular activities. Since the food is usually in the 
mouth for a very brief period a nervous regulation with its rapid onset and high 
precision in action may, from a functional point of view, seem more appropriate 
than an endocrine regulation to control the glands acutely. On the whole, few 
studies have been devoted to acute hormonal effects on salivary glands. 
Aldosterone has a great effect on the electrolyte composition on the parotid 
saliva of the sheep (Blair-West et al., 1967). Upon a latent period (90-120 min), 
of about two hours, it increases the sodium uptake in the duct system. However, 
its effect on human saliva is small. There are studies reporting a sparse fluid 
secretion from the rat submandibular gland upon administration of secretin and 
cholecystokinin (Iwabuchi & Masuhara, 1994; Takai et al., 1998) and two short 
notes reporting increases in amylase concentration in resting flow of saliva from 
the human parotid gland upon infusions of gastrin, secretin and cholecystokinin 
(Mulcahy et al., 1972; Matfertheiner P et al., 1980). Moreover, pentagastrin 
infusion increases the saliva content of epidermal growth factor in humans 
(Konturek et al., 1989). On the other hand, gastrin and secretin were without 
effect on volume or protein output of parotid saliva in the dog (Clendinnen et al., 
1970), while gastrin inhibited on-going secretion of saliva in the sheep (Grovum 
& Leek, 1988), and secretin was without effect on mucous secretion in humans 
(Descos F et al., 1973). No systematic investigations on the secretory effect of 
gastro-instestinal hormones on salivary glands seem to be on record. The 
present study, using the rat as the experimental animal, focuses on the 
hormones gastrin, cholecystokinin and melatonin, which are all released in 
response to a meal (Konturek & Konturek, 2000; Heuther, 1994; Bubenik et al., 
2000; Rice et al., 1995; Ingenito et al., 1986). Though melatonin is usually 
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associated with the corpus pineale and the circadian rythm, high concentrations 
are to be found in the intestines (Bubenik, 1980; Heuther, 1994). 
Gastrin was the second hormone to be described (Edkins 1905). It is released 
from endocrine cells in the antrum and duodenum. It is initially synthesized as 
progastrin and finally processed to amidated gastrin. Gastrin may occur in a 
number of molecular forms, in humans mainly as G-17 and G-34 (Shulkes & 
Baldwin, 1997; Dockray et al., 2005). Gastrin stimulates acid secretion via two 
routes, by a direct action on the parietal cells and indirectly by causing the 
release of histamine from the enterochromaffin-like cells. It is also trophic to the 
gastric mucosa. Moreover, it stimulates the pancreatic gland to release protein. 
Gastrin is released by sight and smell of appetizing food as well as by food in the 
mouth through vagal activity and by food in the stomach through long reflexes 
(involving the central nervous system), short reflexes and digestive products 
(Kwiecien & Konturek, 2003). Pentagastrin possesses the same biological 
activity as native gastrin and is usually used for clinical and experimental 
purposes (Johnston & Jepson, 1967). 
 
Cholecystokinin is located in endocrine cells of the duodenum, and was first 
shown to contract the gallbladder (Ivy & Oldberg, 1928) and later found to cause 
the release of enzymes from the pancreas (Harper and Raper, 1943). Also 
cholecystokinin may occur in various molecular forms, in humans 
cholecystokinin-33 and -22 dominate (Rehfeld, 2004). Apart from the effects 
already mentioned, cholecystokinin also stimulates bicarbonate secretion from 
the gastric mucosa and the exocrine pancreatic gland as well as pepsinogen 
secretion, and it inhibits gastric emptying and further, provides signals for satiety. 
Cholecystokinin is thought to be released by intraluminal products of digested fat 
and protein (Wank, 1995). 
 
Cholecystokinin shares the same carboxyl heptapeptide as gastrin at the end of 
the biologically active part of the molecule. Consequently, they may act at the 
same receptors and evoke the same response. The cholecystokinin/gastrin 
family interacts with at least two receptors, cholecystokinin A and B receptors, 
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which belong to the G-protein-coupled receptor family (Wank, 1995). A third type 
of high-affinity receptor for cholecystokinin in the stomach, the gastrin receptor 
(Soll et al., 1984), turned out to be identical with the cholecystokinin B receptor. 
The two types of receptors are highly homologous, having 48% amino acid 
identity. Besides these traditional receptors, homo- and heterodimerization of 
cholecystokinin A and cholecystokinin B receptors have been demonstrated 
(Cheng et al., 2003). 
 
Melatonin was discovered in the pineal gland by Lerner (1958). It is synthesized 
in a variety of tissues. In the intestinal mucosa, melatonin is confined to the 
enterochromaffin cells, also storing the related serotonin. The amount of 
melatonin in the intestines is about 400 times that in the pineal gland (Bubenik, 
1980; Huether, 1994). Melatonin stimulates duodenal bicarbonate secretion and 
pancreatic amylase secretion (Sjöblom & Flemström, 2003; Jaworek et al., 
2004). Many of the melatonin’s regulatory roles are mediated through high 
affinity and G protein-coupled receptors, melatonin 1 and melatonin 2 receptor 
subtypes. A close relationship between food intake and melatonin release from 
the intestines has been reported (Bubenik, 2002; 2008). 
 
Salivary gland inflammation may cause hyposalivation, Sjögren´s syndrome 
being the classic example (Grišius & Fox, 1998). However, a reduced flow of 
saliva may also allow microorganisms to invade the salivary gland duct system 
and the secretory cells, resulting in chronic gland inflammations (Van-Winkelhoff 
& Boutaga, 2005). As a consequence of the inflammation, the oral health is 
jeopardized. In recent years, β-defensins, a group of small antimicrobial peptides 
of the innate immune system have come into focus as a part of the defense 
system. They have a broad spectrum of activity against Gram-positive and 
Gram-negative bacteria, fungi and virus. β-Defensins are expressed along the 
epithelial surfaces of the digestive tract, including the oral mucosa, gingival 
tissue, tongue and salivary glands, and they appear in the saliva (Schutte & 
McCray, 2002; Dunche et al., 2001). 
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Interestingly, cholecystokinin and melatonin, in particular, are reported to display 
anti-inflammatory actions, e.g. inhibiting neutrophil infiltration and neutralizing 
reactive oxygen and nitrogen compounds, and may be thought of as potential 
therapeutic options (Carrasco et al., 1997; Ling et al., 2001; Reiter, 2001; Barlas 
et al., 2004; Jahovic et al., 2004; Topal et al., 2005). Nitric oxide seems to play a 
key role during inflammation, and may both promote and inhibit the process. 
 
Nitric oxide is synthesized from L-arginine and molecular oxygen by the enzyme 
nitric oxide synthase (NOS). Nitric oxide has the ability to diffuse through cell 
membranes. Three isoforms of NOS have been identified, the neuronal type 
(nNOS), the endothelial type (eNOS), both constitutively expressed, and the 
inducible type (iNOS). Neuronal NOS is expressed both in nervous tissue and in 
epithelial cells. Neuronal NOS as well as endothelial NOS are activated in 
response to a generated calcium signal, for instance, by nerve activity or the 
exposure of the blood vessels to shear stress. Nitric oxide formed in response to 
the two constitutive NO-synthases activates soluble guanylate cyclase to form 
cyclic GMP (Moncada et al., 1991). The inducible NOS is activated by cytokines 
and bacterial lipopolysacharide, and nitric oxide may originate from neutrophils 
and macrophages. Nitric oxide released upon the activity of inducible NO-
synthase is not thought to work through the cGMP-pathway. It is cytotoxic (partly 
because it interacts with oxygen derived radicals) not only for invading 
microorganisms but also for the host immune cells. In Sjögren´s syndrome, 
inducible NO-synthase is present in acinar and ductal cells (Konttinen et al, 
1997). 
 
In the first section of this Thesis, a trace secretion from the submandibular gland, 
but not from the parotid gland, occurred in response to the cholecystokinin 
analogue desulfated CCK-8 and to the gastrin homologue pentagastrin (1). 
 
In previous studies from this laboratory on parasympathetic non-adrenergic, non-
cholinergic transmitter mechanisms in salivary glands, neuropeptides were found 
to cause secretion of proteins and to evoke exocytosis of acinar secretory 
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granules without any accompanying overt secretion of fluid (Ekström, 1999). The 
“occult” neuropeptide-evoked protein secretion was revealed by a subsequent 
wash-out flow of saliva in response to volume-producing secretagogues 
administered to the blood stream. By applying this in-vivo approach, a basal 
secretion of protein/amylase was initially demonstrated and possible influences 
on this secretion were tested in the next section (2). 
 
This basal secretion served as reference to the response of the submandibular 
(section 3) and parotid glands (section 4) upon administration of the 
hormone/hormone-analogues. The outcome made the parotid gland to become 
the primary study object. In this gland, amylase is the major exportable protein, 
being 35% of total secretory protein (Robinovitch et al., 1977). It reflects acinar 
secretion, while total protein reflects both acinar and ductal secretion. The 
following experiments were designed to define whether the hormone/hormone-
analogues evoked secretion by a direct effect on the gland cells. In this 
connection, the types of receptors involved were examined as well as their 
glandular expression. 
 
In the next section (5), the effect on the glandular synthesis of protein following 
exposure to pentagastrin was investigated. Receptors involved in the observed 
increase were examined by the use of antagonists and further, the consequence 
of the receptor blockade on the basal protein synthesis was defined. 
 
Next (6), the involvement of NO generation in the protein/amylase secretion 
(pentagastrin and melatonin) as well as in the protein synthesis (pentagastrin) 
was considered. Moreover, particular attention was paid to the contribution of the 
neuronal type of NO-synthase to the generation of NO (Ekström & Sayardoust, 
2003). 
 
Cholecystokinin may serve as a transmitter in the autonomic nervous system 
(Rhefeld, 1980), and was suggested to act as parasympathetic non-adrenergic, 
non-cholinergic transmitter evoking secretion of saliva from the submandibular 
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gland of the rat (Takai et al., 1998). In section 7, the possibility that not only 
cholecystokinin of gastro-intestinal origin but also cholecystokinin of nervous 
origin contribute to the regulation of the secretory activity of the parotid gland 
was explored. 
 
In the last section (8) of this Thesis, an experimental model was worked out for 
studies on inflammation and its resolution, using the rat parotid gland exposed to 
the retrograde ductal injection of bacterial lipopolysaccharide. Myeloperoxidase 
activity reflected the neutrophil infiltration of the gland tissue, and the 
antimicrobial β-defensins were found to increase. In a number of experiments, 
the effect of melatonin and cholecystokinin on the increase in myeloperoxidase 
activity following the local injection of lipopolysaccharide was followed and 
further, the involvement of inducible and neuronal NO-synthases was explored. 
 
In summary, the objective of this Thesis is to define the roles of the traditional 
gastro-intestinal hormones gastrin and cholecystokinin as well as the role of the 
non-traditional gastro-intestinal hormone melatonin in the regulation of glandular 
activities associated with secretion and with special attention to: 
 
1) The secretion of proteins and the synthesis of proteins. 
2) A direct or indirect action of the hormones on the glands, the types of 
receptors involved and the nitric-oxide dependency. 
4) Cholecystokinin as a possible parasympathetic non-adrenergic, non-
cholinergic transmitter; and further, to define an anti-inflammatory role in the 
lipopolysaccharide-induced gland inflammation with respect to: 
5) Melatonin and cholecystokinin, mediating receptors and the involvement of 
neuronal and inducible types of nitric oxide-synthase in the inflammatory 
response. 
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MATERIAL AND METHODS 
 
Adult female rats of a Sprague Dawley strain were used. They were maintained 
on a pelleted standard diet and tap water ad libitum. Prior to the acute 
experiments, the rats of Papers II–V were fasted over-night (but for a study group 
in V). The experiments were approved by the local animal welfare committee, 
Gothenburg, Sweden. 
 
For the chronic experiments, the rats were anaesthetized with a combination of 
pentobarbitone (20 mg/kg, I.P.) and ketamine (50 mg/kg, I.M.); buprenorphine 
(0.015 mg/kg, S.C.) was given as an analgesic. 
 
For the terminal experiments, the rats were anaesthetized with pentobarbitone 
(55 mg/kg, I.P., additional doses were given intravenously as required). The body 
temperature was kept at about 38º C by using a heating blanket connected to a 
rectal probe. A tracheal cannula was fitted. The rats were provided with a femoral 
venous catheter on both sides; one serving as a conduit for hormone/hormone-
analogue infusion and the other for injection of methacholine and various 
blockers. In some types of the experiments, receptor antagonists were 
administered intraperitoneally (VII). 
 
At the end of the experiments, the animals were killed, still under pentobarbitone-
anaesthesia, by exsanguinations after cutting the abdominal aorta. 
 
Preliminary surgery 
Combined parasympathetic postganglionic denervation and sympathetic 
postganglionic denervation was achieved by avulsion of the auriculo-temporal 
nerve (Khosravani et al., 2006) and avulsion of the superior cervical ganglion 
(Alm & Ekström, 1977). The wound was sutured and the animals were allowed to 
recover. The acute experiments were performed 1-2 weeks postoperatively 
(allowing time for nerve degeneration). 
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Duct-cannulations: collection of saliva or retrograde ductal injections 
The parotid duct was exposed on the masseter muscle, close to the mouth, by a 
skin incision. The submandibular duct was exposed under the myelohyoideus 
muscle. To collect saliva a fine polyethylene tube (filled with distilled water) was 
inserted, under the dissection microscope, into the duct. Saliva was either 
collected on pre-weighed filter papers or in ice-chilled pre-weighed EppendorfTM 
tubes and then they were re-weighed. The saliva was frozen (-20° C) and stored 
(-70° C). The specific density of the saliva was taken to be 1.0 g/ml. 
 
For retrograde ductal injection (Alm & Ekström, 1976), a syringe filled with LPS 
(a concentration of 0.2 mg/ml in sterile saline) or just saline as control, attached 
to a fine polyethylene tube was inserted into the duct and 0.04ml of the solution 
was injected towards the gland during 5 seconds. The tube was then cut open 
for 5 seconds to allow overflow if any, and was closed 2-3 min later by heating; 
then, the wound was sutured. The gland on the contralateral side was untreated. 
 
Terminal surgery: denervation and/or evisceration 
Combined parasympathetic and sympathetic denervation of the parotid gland 
was the same surgical procedure as for the chronic procedure (see above, I, V). 
Evisceration was performed by ligating the coeliac artery (which interrupts the 
arterial blood supply to the liver), the superior mesenteric artery and the hepatic 
vein. The esophageus and the rectum were divided, and the stomach, spleen, 
pancreas and the small and large intestines were removed (I, V; in V denervation 
and evisceration were performed in the same rat). 
 
Fluid secretion: submandibular gland 
Pentagastrin and desCCK-8 were infused intravenously over a period of 1 hour. 
There was no secretion from the parotid gland but a trace secretion appeared 
from the submandibular gland (I). Saliva was collected over 5- min periods by 
pre-weighed filter paper. The experiments were performed in the presence of α- 
and β-adrenoceptor antagonists as well as atropine. 
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Metacholine-evoked wash-out secretion: the standard protocol 
 
 
The Figure, showing the mean responses of seven rats, illustrates the 
experimental protocol. Three intravenous bolus injections of methacholine (5 
µg/kg) given with 10 min intervals, were followed by a 5 min pause (during which, 
when appropriate, blockers were given), then a 10 min long period of intravenous 
infusion of hormone/hormone-analogues or saline (horizontal line; in the present 
case melatonin 25 mg/kg) followed. Ten minutes after the end of the infusion, 
methacholine was once again injected every 10 minute over 30 minutes. For 
statistical evaluation, the response to the fourth methacholine injection was 
compared to that of the third, set to 100%. The methacholine response was 
prompt and with a short duration (< 1 min). The saliva produced in response to 
an injection was collected in ice-chilled pre-weighed tubes. The experiments 
were performed in the presence of α- and β-adrenoceptor antagonists. 
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Stimulation of the parasympathetic auriculo-temporal nerve 
The auriculo-temporal nerve was stimulated at supramaximal voltage (7 V, 2 ms) 
using a Grass S48 stimulator with an isolation unit (Grass SIU 5A), at a 
frequency of either 10 Hz or 40 Hz (IV). Saliva was collected in pre-weighed ice-
chilled tubes during each stimulation period. The experiments were performed in 
the presence of α- and β-adrenoceptor antagonists and, when appropriate, 
atropine as well. Six stimulation periods were applied to nerve, each of a 
duration of 3 min in the atropinized rats and of 2 min in the non-atropinized rats. 
The interval between two stimulation periods was 5 minutes. Immediately after 
the end of the second stimulation period, the CCK-A receptor antagonist 
lorglumide was injected intravenously. In the same animal, the CCK-B receptor 
antagonist itriglumide was injected intravenously immediately after the end of the 
fourth stimulation period. As to controls, the same stimulation protocol was 
followed but saline replaced the hormone-receptor antagonists. For the statistical 
evaluation, the response to the third stimulation period (in the presence of the 
CCK-A receptor antagonist) was compared to that of the second stimulation 
period (set to 100%) and the response to the fifth stimulation period (in addition, 
in the presence of the CCK-B receptor antagonist) to that of the fourth 
stimulation period (set to 100%). 
 
Assay of protein and amylase 
The salivary protein content was analysed by the method of Lowry et al. (1951) 
and expressed in terms of concentration (µg/µl saliva), using bovine serum 
albumin as standard (I, II, IV, V). The salivary amylase activity was measured by 
an enzymatic colorimetric test (Roche Diagnostics), using α-4-
nitrophenylmaltoheptaoside (4NP-G7) as substrate (Hägele et al., 1982). One 
unit (U) of catalytic activity of α-amylase is defined as the hydrolysis of 1 µmol of 
4NP-G7 per min per µl, being equivalent to the definition of the international unit. 
The salivary amylase was expresessed in terms of concentration (U/µl) or as 
total otput (U). 
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Protein synthesis: [3H] leucine incorporation 
To measure the incorporation of [3H]leucine into trichloroacetic acid-insoluble 
material of the parotid gland, 500 µCi/kg of leucine in 0.5 ml saline, was injected 
intravenously 30 min after the end of an hour long intravenous infusion period of 
pentagastrin (20 µg/kg/h). The experiments were performed in the presence of α- 
and β-adrenoceptor antagonists as well as atropine. CCK-receptor antagonists 
and nitric oxide synthase inhibitors were administered before the infusion period. 
The animal was killed 15 min after the [3H]leucine administration by 
exsanguination, and the parotid glands of both sides were removed, washed in 
saline, pressed between gauze pads, placed on filter paper to remove adherent 
tissue (if any) and to absorb additional fluid, weighed, frozen (-20° C) and stored 
(-70° C) until processed within a week (III). Following the processing of the gland 
tissue, the final precipitate was analysed in a scintillation counter. The amount of 
radiolabelled leucine was expressed as disintegrations per min per mg of gland 
tissue. In each study group, two rats were paired, based on age and body 
weight, before the experiment began, one to serve as experimental animal and 
the other as control animal. The pair of animals was treated concomitantly and in 
the same way apart from the difference in type of infusion (and pretreatment of 
drugs) and furthermore, the glands of each pair were processed and analysed at 
the same time. 
 
Immunoblotting: CCK- and melatonin-receptors 
Western blot technique was used to determine the expression of CCK- and 
melatonin- receptor proteins in the salivary glands (and for comparison the 
pancreatic gland and antrum of the stomach). The tissues were homogenized 
and centrifuged. The supernatants were analysed for protein content with an 
assay from Bio-Rad Laboratories AB, using serum albumin as standard. Applying 
equal amounts of protein, the proteins in the homogenates were electroblotted 
and later application of first primary and later secondary antibodies performed. A 
high-performance chemoluminescence film was developed and the membranes 
were scanned (Paper I, V). 
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Tissue myeloperoxidase activity: neutrophil infiltration 
Tissue myeloperoxidase activity was determined according to Hillegas et al. 
(1990) and Kuebler et al. (1996) (VI, VII). Though, the assay is not thought to be 
influenced by other peroxidases (Kuebler et al., 1996), a selective inhibitor 
(Dapsone, diaminodiphenylsulfone) of peroxidases (and not of 
myeloperoxidase), was used to ascertain the specificity of the assay (Thomas et 
al., 1994). One unit of enzyme activity was defined as the amount of 
myeloperoxidase present that caused a change in absorbance of 1.0 per min at 
37˚C. Myeloperoxidase activity was expressed as total activity (units per whole 
gland per minute). 
 
Histology: neutrophil infiltration 
To confirm glandular cell infiltration, as a response to lipopolysaccharide, in the 
parotid and submandibular glands, tissue specimens were stained for 
hematoxylin and eosin (VI). 
 
ELISA assay: β-defensins 
Based on a sandwich ELISA protocol (Faurschou et al., 2002) an indirect ELISA 
for detection and quantification of rat β-defensins 1, 2 and 3 was designed (VI). 
The amounts of β-defensins were expressed in terms of µg per 100 mg gland 
tissue. 
 
Chemicals 
Lipopolysaccharide (Escherichia coli LPS 0111:B4; purified by gel-filtration 
chromatography), Pentagastrin, cholecystokinin octapeptide desulfated 
(desCCK-8 ) or sulfated (sCCK-8), melatonin, CCK-A receptor antagonist CR-
1409 (lorglumide), CCK-B receptor antagonist CR 2945 (itriglumide), melatonin 
receptor antagonist luzindole, metacholine hydrochloride, non-selective nitric 
oxide-synthase inhibitor L-NAME, inducible nitric oxide-synthase inhibitor L-NIL, 
atropine sulphate and propranolol hydrochloride and Dapsone 
(diaminodiphenylsulfone) were from Sigma Chemicals, phentolamine mesylate 
was from Novartis Pharma AG, [3H]leucine was from Amersham Biosciences, 
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neuronal nitric oxide-synthase inhibitor N-PLA from Cayman Chemical Company 
and pentobarbitone sodium was from Apoteksbolaget, Stockholm, Sweden. 
 
Statistical analyses 
Statistical significances of differences were calculated by Student’s t-test for 
paired or unpaired values or by one-way analysis of variance (ANOVA) followed 
by Fisher’s protected least-significant difference. Probabilities of less than 5 % 
were considered significant. Values are means ± S.E.M. 
 
 
 
RESULTS AND DISCUSSION 
 
Basal values: methacholine- and nerve evoked saliva 
The mean volume of saliva secreted from the submandibular gland was 16 µl in 
response to an intravenous bolus dose of methacholine (5 µg/kg), while the 
mean salivary protein concentration was 0.5 µg/µl. The volume of parotid saliva 
secreted was 9.5-11.7 µl to methacholine 5 µg/kg; the mean salivary 
concentration of protein was within the range of 2.0-5.1 µg/µl, while that of 
amylase activity was 0.6-1.6 U/µl. 
 
In response to parasympathetic stimulation at 10 Hz, the parotid gland secreted 
a mean of 52 µl/min saliva in the absence of atropine, and in its presence 8 
µl/min, the mean amylase concentration being 1.0 U/µl and 10 U/µl, respectively. 
At 40 Hz, in the presence of atropine, the mean flow rate was 23 µl/min and the 
amylase concentration was 6 U/µl. 
 
Since in the studies using the wash-out design, the post-infusion volume of 
saliva to methacholine was the same at that to the pre-infusion volume of saliva, 
protein and amylase were expressed as concentrations (Paper I, II, IV and V). 
On the other hand, volume changes occurred when using the experimental 
protocol for nerve stimulation. Therefore, figures for the total output of amylase 
were also used. 
Gastro-intestinal hormones and salivary glands 
 18 
(1) Fluid secretion 
There was no resting flow of saliva from the submandibular and parotid glands in 
the anaesthetized animals. In the submandibular gland, but not in the parotid 
gland, pentagastrin and desCCK-8 evoked a trace secretion in the presence of 
muscarinic- and α- and β-adrenergic- receptor blockade (I). No secretion of 
saliva was observed in response to melatonin from the two types of glands (V, 
and unpublished observation with respect to the submandibular gland). 
 
(2) Basal (constitutive) secretion 
A continuous secretion of protein/amylase occurred from the both glands (I, II, 
V). This was revealed by an increase of the interval of the repeated wash-out 
injections of methacholine (from 10 min to 25 min). The concentration values 
being elevated by 10-30% in the parotid saliva and by 70% in the submandibular 
saliva (only protein), while the volume of saliva secreted to methacholine 
remained unchanged. (I, II, V) 
 
The elevation occurred in the presence of α- and β-adrenergic receptor 
blockade, and was unaffected by the various hormone-receptor antagonists and 
NO-synthase inhibitors tested. The increase is presently attributed to on-going 
constitutive secretion. In this connection, it should be mentioned that the 
phenomenon occurred also after acute denervation of the glands and 
evisceration (I, V). 
 
(3) Protein secretion of the submandibular gland 
Pentagastrin and desCCK-8 evoked higher figures for the protein concentration 
in the wash-out saliva than control values (125% and 114%, respectively, versus 
70%) but a significant difference was not attained under the present 
experimental set-up (I). The volume of the wash-out saliva to methacholine 
remained unchanged. Subsequent observations on the secretion of protein were 
focused on the parotid gland. 
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(4a) Protein and amylase secretion of the parotid gland 
The protein concentrations of the wash-out saliva to methacholine (as compared 
to pre-infusion values) were significantly higher than in corresponding controls, in 
response to pentagastrin by 141% (158% and 145% versus 11%, I, II), for 
desCCK-8 by 74% (85% versus 11%, I) and for melatonin by 29-70% (53-94%, 
depending on dose, versus 24%, V). Similar effects were observed with respect 
to the amylase concentration, being for pentagastrin by 105% (127% versus 
22%, II), desCCK-8 by 45% (68% versus 23%, I) and melatonin by 27-64% (53-
90%, depending on dose, versus 26%, V). Apart for melatonin, the observations 
were performed on non-fasted rats. However, food intake did not affect the 
magnitude of the response to melatonin (V). 
 
The volume of the wash-out saliva in response to methacholine remained 
unchanged. Therefore, any change in the concentrations of protein and amylase 
activity reflects a change in the total output of protein and amylase. The changes 
in acinar amylase output went in parallel with the changes in total protein output. 
 
The elevated protein and amylase outputs were not a reflection of synergistic 
interactions between the hormones and methacholine, as shown by a change in 
the standard protocol (I, V). Instead of injecting the first post-administration 
wash-out dose of methacholine 10 min after the end of the period of hormone 
infusion, an injection of methacholine was given already at 5 min and then, 
followed by “the ordinary” injection of methacholine 5 min later (i.e. 10 min after 
the end of infusion period). If a potentiating effect was at work at 10 min, 
enhanced responses would be expected despite the preceding methacholine 
injection just 5 min after the infusion period. With respect to both pentagastrin 
and melatonin, neither amylase nor proteins were significantly elevated 
compared to the pre-infusion period. Importantly, the amylase and protein 
responses to the injection 5 min after the end of the infusion were markedly 
increased, while the volume of saliva remained unchanged. 
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The hormones most probably evoked protein/amylase secretion by a direct 
action on the secretory cells of the glands (I, II, V). The responses were still 
evoked after excluding potential influences exerted by the central nervous 
system or autonomic ganglia and circulating catecholamines as well as the 
stomach, the intestines, the spleen and the liver. 
 
(4b) Cholecystokinin and melatonin receptors involved in the 
protein/amylase secretion 
The CCK-A receptor antagonist lorglumide prevented completely the 
protein/amylase response to pentagastrin and desCCK-8. In the presence of the 
CCK-B receptor antagonist itriglumide, the glands still responded to both 
desCCK-8 and pentagastrin. However, the pattern was not uniform, since the 
response to desCCK-8 was unaffected by itriglumide, while the response to 
pentagastrin was significantly less than in the absence of itriglumide (I, Fig. 2). 
The melatonin receptor blocker luzindole, prevented the expected 
protein/amylase increase to melatonin. Luzindole displays a higher affinity for 
MT2 receptors than MT1 receptors. Presently, it is not possible to decide 
whether just MT2 receptors or also MT1 receptor subtypes were involved in 
mediating the secretory response. 
 
The pancreatic amylase secretion evoked by melatonin is thought to depend on 
a melatonin-induced release of cholecystokinin, which in turn activates a vago-
vagal reflex eliciting the pancreatic gland to secrete amylase (Leja-Szpak et al., 
2004). As shown by the use of the CCK-A receptor antagonist lorglumide the 
melatonin-induced protein/amylase response of the parotid gland did not require 
cholecystokinin as intermediary agent. 
 
(4c) Expression of cholecystokinin and melatonin receptors 
Appropriate receptor antibodies recognized both CCK-A and CCK-B receptor 
proteins in the parotid and submandibular glands (I). The expression of these 
receptors did also appear in chronically denervated parotids. Likewise, both MT1 
and MT2 receptor proteins were identified in the parotid gland (V). The specific 
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binding of the receptor proteins was tested in the presence of blocking peptides 
or in the absence of primary antibodies, and in neither case did the expected 
protein bands appear. 
 
(5) Protein synthesis 
A 17% increase in the protein synthesis of the parotid gland, as judged by the 
incorporation of [3H] leucine into trichloroacetic acid-insoluble materials, followed 
upon infusion of pentagastrin over one hour (under muscarinic and α- and β-
adrenoceptor blockade, III). In the presence of the CCK-A receptor antagonist 
lorglumide or the CCK-B receptor antagonist itriglumide, the expected increase 
to pentagastrin was not only absent, but also further reduced, below the basal 
value (by 16-12%) of controls (not exposed to the CCK-receptor antagonists). 
The further reduction (below control value) suggested that the CCK-receptors 
were exposed not only to exogenous pentagastrin but also to endogenous 
stimulation. Support for this idea was gained when the control glands (under 
basal conditions) were subjected to either of the two CCK-receptor antagonists 
and displaying a decrease in protein synthesis of about the same magnitude (by 
22-17%). Evidently, the effect of the two CCK-receptor antagonists was non-
additive, since upon combined administration the magnitude of the reduction was 
not further increased. The non-additive effect may suggest that both receptor 
types, share a common pathway intracellularly. 
 
In the rat parotid gland, most of the protein synthesis is directed towards 
producing secretory products (Sreebny, 1971). The synthesis of protein and 
amylase is thought to be the consequence of a direct agonist action temporally 
dissociated and independent of the agonist-evoked secretory activity (Grand & 
Gross, 1969). This view is supported by the fact that both types of CCK-
receptors were involved in the protein synthesis, while the protein/amylase 
secretion seemed mainly to depend on the CCK-A receptor (2d). 
 
Since, the CCK-receptor antagonists affected the protein synthesis under “basal 
condition”, but did not affect the protein/amylase secretion during “basal 
Gastro-intestinal hormones and salivary glands 
 22 
condition”, it may be concluded that the intracellular mechanisms associated with 
cholecystokinin-receptor mediated protein synthesis is more sensitive to low 
graded stimuli than the intracellular mechanisms associated with cholecystokinin-
receptor mediated protein secretion. 
 
The CCK-receptor mediated stimulation of an early and rapid protein synthesis in 
the parotid gland presently observed is probably associated with the synthesis of 
secretory proteins rather than with hypertrophy or hyperplasia. While prolonged 
treatment with pentagastrin or cholecystokinin is without effect on the weight of 
the rat parotid gland, the pancreatic gland gains in weight in response to the 
treatment (Maystone & Barrowman, 1971; Månsson et al., 1990; Axelson et al., 
1996). 
 
On-going studies of ours (H. Çevik Aras, T. Godoy and J. Ekström) show also an 
infusion of melatonin to induce protein synthesis (35%) in the rat parotid gland, 
partially dependent on neuronal type NO-synthase and affected by luzindole. 
 
(6) NO-dependent and NO-nondependent protein secretion and protein 
synthesis 
Roughly, two-thirds of the increase in protein and amylase secretion (II) in 
response to pentagastrin or melatonin could be related to NO-generation. The 
selective neuronal type of NO-synthase inhibitor N-PLA (Zhang et al., 1997) 
showed about the same efficacy as the non-selective NO-synthase inhibitor L-
NAME. 
 
The expected increase (23%) in glandular protein synthesis to pentagastrin was 
prevented by the two NO-synthase inhibitors (III), thus illustrating its NO-
dependency. NO-synthase inhibition did not affect the “basal” protein synthesis, 
in agreement with previous work (Sayardoust & Ekström, 2004). However, the 
“basal“protein synthesis was reduced (17-23%) by the cholecystokinin-receptor 
antagonists (III). Thus, already under basal conditons, the cholecystokinin-
receptors of the parotid gland were subjected to stimulation, probably by 
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circulating hormones, and this did not require the generation of NO. The results 
suggest that strong rather than weak stimuli of the CCK-receptors are necessary 
to activate the neuronal type NO-synthase. The varying degree of NO-
dependency presently found, is in agreement with earlier observations in the 
parotid gland (Sayardoust & Ekström, 2003). 
 
(7) Effects of cholecystokinin receptor antagonists on the parasympathetic 
transmission 
No support was gained for the view that cholecystokinin is one of the transmitters 
involved in mediating the parasympathetic non-adrenergic, non-cholinergic 
secretion of fluid and of protein/amylase in the parotid gland of the rat (IV). The 
fluid and amylase secretion rate (under α- and β-adrenoceptor blockade) at a 
stimulation frequency of 10 Hz or of 40 Hz of the auriculo-temporal nerve was 
neither affected by the CCK-A receptor blocker lorglumide nor by the CCK-B 
receptor blocker itriglumide, and this was the case for both non-atropinized and 
atropinized rats. Thus, under physiological conditions cholecystokinin and 
gastrin, acting on the cholecystokinin receptors of the glands, are likely to be of 
endocrine origin rather than of nervous origin. 
 
A characteristic feature of the non-adrenergic, non-cholinergic secretion is that it 
fatigues in response to repeated sequences of stimulation and, in particular, 
when a high frequency of stimulation is applied to the nerve. The phenomenon is 
attributed to the depletion of the neuropeptide stores of the nerve terminals 
(Ekström, 1999). This depletion might be the explanation to the decreased fluid 
response from the submandibular glands, observed by Takai and coworkers 
(1998), upon repeated parasympathetic stimulation at a high frequency after 
administration of lorglumide. 
 
(8a) Lipopolysaccharide (LPS)-induced gland inflammation and β-defensins 
The presence of the three subtypes of the antimicrobial β-defensins was 
demonstrated in the rat parotid gland using an ELISA assay. In response to the 
intraductal injection of LPS, the levels of β-defensin 1 and 3 were elevated 3 to 6 
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hours post-injection (by 41-30% and 15-65%, respectively), while the level of β-
defensin 2 was unaffected during the observation period. When examined at 6 
hours, the LPS-treated parotid glands showed a marked glandular infiltration of 
neutrophils and further, the myeloperoxidase activity was increased 9 to 10-fold; 
at the early stage (3 hours), the increase was as much as 12-fold (VI, VII). 
 
The three subtypes of β-defensins were not detected in the submandibular and 
sublingual glands. Though, the myeloperoxidase activity was 6-fold increased in 
response to LPS in the submandibular glands, neither of the β-defensins was 
detected. Previous in vitro findings do also show various patterns of response to 
LPS, which might suggest different roles for the three subtypes in the defense 
mechanisms of the glands (Feucht, 2003; Fahlgren, 2004). 
 
(8b) Anti-inflammatory actions of cholecystokinin and melatonin 
A direct relationship between tissue myeloperoxidase activity and the number of 
neutrophils exists (Bradley et al., 1982). Both cholecystokinin and melatonin 
markedly, and dose-dependently, reduced the myeloperoxidase response to the 
intraductal administration of LPS (VII). Whereas both sulfated and desulfated 
forms of CCK-8 have been shown to exert anti-inflammatory actions, most 
previous works have focused on the sulfated form (Carrasco, 1997; Ling et al., 
2001; Cong et al., 2002; Wu et al., 2008), which was also the form presently 
studied. The expected 10-fold rise in the activity of myeloperoxidase (at 3 hours 
following the intraductal LPS administration) was just 3.5-fold in the presence of 
either cholecystokinin or melatonin administered intraperitoneally. The anti-
inflammatory action exerted by cholecystokinin was partially due to the 
involvement of CCK-A receptors, but not to CCK-B receptors. As judged by the 
lack of effect of luzindole to attenuate the anti-inflammatory action of melatonin, 
melatonin did not exert its action by MT2 receptors. Though luzindole also has a 
certain affinity for MT1 receptors (Dubocovich et al., 1998), it might be too early 
to classify the anti-inflammatory action of melatonin (with respect to 
myeloperoxidase activity) as a non-receptor phenomenon. 
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(8c) Anti-inflammatory actions of non-specific and specific NO-synthase 
inhibitors 
The LPS-induced increase in myeloperoxidase activity was abolished by the 
non-specific NO-synthase inhibitor L-NAME (VII). Each of the specific inhibitors 
for inducible NO-synthase, L-NIL, and for neuronal NO-synthase, N-PLA, halved 
the response. The neuronal type of NO-synthase mobilized by LPS was of non-
nervous origin. This was confirmed in the glands subjected to combined chronic 
postganglionic parasympathetic and sympathetic denervation, the marked 
increase in myeloperoxidase activity in response to LPS was more than halved 
by N-PLA. 
 
Whether sCCK-8 and melatonin exerted their anti-inflammatory action by 
inhibiting NO-generation in the inflamed parotid gland is unknown and it is 
presently under study. Melatonin has been shown to inhibit LPS-induced activity 
of inducible NO-synthase in liver and lungs in rats (Crespo et al., 1999). 
 
 
 
GENERAL DISCUSSION 
 
The nervous and hormonal control of the exocrine secretion in the digestive tract 
is usually divided into separate phases depending on the location of the stimulus: 
the cephalic phase initiated by sight and smell of the food or by food in the 
mouth, the gastric phase by distension, a high pH and peptides and the intestinal 
phase by a low pH, osmolarity, distension, amino acids and fatty acids. The 
gastric secretion is conveniently divided into those three distinct phases, though 
it should be realized that they overlap each other except at the start of the food 
intake. Whereas nervous activity dominates during the cephalic phase, 
endocrine activity dominates during the intestinal phase (Konturek & Konturek, 
2000; Raybould et al., 2003). 
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The present Thesis, using the rat parotid gland as experimental in vivo model 
organ, gives a new perspective to the control of salivary secretion by adding, to 
the well-established cephalic phase, both a gastric and an intestinal phase as 
possible sites for the control of salivary gland secretion. Recent observations of 
ours do also show all three major salivary glands of the rat to be supplied with 
cholecystokinin A and B receptors and further, by melatonin 2 receptors (J. 
Ekström, T. Grunditz, H. Çevik Aras, A. Riva & H. Helander, to be published). 
With respect to the parotid gland, presently in focus, the type A of 
cholecystokinin receptors was preferentially located to the acini, while the type B 
was preferentially located to the ducts; the melatonin 2 receptor was more evenly 
divided between the two locations. Moreover, we found the major salivary glands 
in humans to be supplied with these types of receptors. Preliminary findings did 
also show acini of human parotid gland tissue exposed to pentagastrin to induce 
ultrastructural changes associated with secretory activity and further, to release 
protein (Loy et al., 2008). 
 
The CCK-A receptor shows a high affinity for cholecystokinin and sulfated 
cholecystokinin analogues but a low affinity for gastrin and desulfated 
cholecystokinin analogues. The CCK-B receptors, on the other hand, show about 
the same affinity for gastrin and for cholecystokinin and its desulfated analogues. 
In the present study, no attempt was made on basis of agonist potency to decide 
which type, A or B, of cholecystokinin receptors was involved in the responses. 
The cholecystokinin receptors lorglumide and itriglumide are considered 
selective for CCK-A and CCK-B receptors, respectively (Makovec et al., 1987; 
1999). However, the relative affinities for various antagonists are usually based 
on findings under in vitro conditions and might therefore not be directly applied to 
the functional in vivo situation with respect to potency and selectivity (Ding & 
Håkanson, 1996). Thus, conclusions should be drawn with caution. The use of 
antagonists in the present study, showed the CCK-A receptor to be involved in 
the secretion of protein/amylase, while the contribution of the CCK-B receptor to 
the secretory response was less unambiguous. Both the CCK-A and the CCK-B 
receptors were involved in the synthesis of protein. The CCK-A receptor is 
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usually associated with the motoric activity of the gastro-intestinal tract but is also 
involved in pancreatic secretion, while the CCK-B receptor is associated with 
acid secretion and gastric mucosal growth. Both receptor types seem to 
participate in the secretion of pepsinogen (Blandizzi et al., 1999). Though, 
luzindole is described as a melatonin 2 receptor preferring antagonist, it is too 
early to exclude a role for melatonin 1 receptor in the methacholine evoked 
secretion of protein. The melatonin 1 receptor type was expressed in the parotid 
gland but so far its glandular localization is unknown. Melatonin seems not to 
occur in peripheral nerves and though, this may be the case for cholecystokinin 
(Larsson & Rehfeld, 1979) no support for a transmitter role for cholecystokinin 
was found in the present preparation. 
 
In the present study, the hormone/hormone-analogues mediated their secretion 
and synthesis of proteins partially by NO generation by the activity of neuronal 
type NO-synthase. Their direct action on the parotid gland makes it likely that the 
neuronal type of NO-synthase mobilized was of parenchymal origin rather than of 
nervous origin (Sayardoust & Ekström, 2003). In the rat parotid gland NO-
synthase is present in the parasympathetic innervation but not in the sympathetic 
innervation (Alm et al., 1995, 1997). However, in parotid gland the amount of 
fluid, protein output, protein synthesis and mitotic activity upon stimulation of the 
parasympathetic innervation is independent of NO generation (Sayardoust & 
Ekström, 2006). Likewise, neither the volume of saliva nor the outputs of protein 
and amylase in response to methacholine (under control conditions) were 
presently affected by the non-selective NO-synthase inhibitor or by the neuronal 
NO-synthase inhibitor. In contrast, the protein output, protein synthesis and 
mitotic activity in the rat parotid gland in response to β-adrenoceptor activation 
by sympathetic nerve stimulation or by a β-adrenoceptor agonist are partially 
dependent on NO-generation due to the activity of neuronal type NO-synthase 
(Sayardoust & Ekström, 2003, 2004; Ekström et al., 2004). Compelling evidence 
for the idea of the involvement of neuronal type NO-synthase of parenchymal 
origin is gained in chronically denervated parotids, where β-adrenoceptor 
agonists (but not muscarinic agonists) cause the secretion of protein that is 
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partially blocked by a selective neuronal type NO-synthase inhibitor (Sayardoust 
& Ekström, 2003). Interestingly, NO generation may be dissociated from the 
secretory response. In parotid acinar cells from the rabbit, NO generation caused 
by methacholine is completely inhibited by a non-selective NO-synthase inhibitor 
but the methacholine-induced amylase secretion is not affected (Tsunoda et al., 
2003). Moreover, NO is generated during gland inflammation and also here 
engaging neuronal type of NO-synthase in denervated glands, see below. 
 
The intracellular signalling pathways mobilized by desCCK-8, pentagastrin and 
melatonin eliciting secretion and synthesis of proteins in the parotid gland are 
presently unknown. They evoke, however, a “profile” similar to that of β-
adrenoceptor agonists and vasoactive intestinal peptide rather than to that of 
muscarinic agonists, α-adrenoceptor agonists and substance P. The former 
group, using cAMP intracellularly, produces a small flow of parotid saliva with a 
high protein concentration, whereas the latter group, using Ca 2+ intracellularly 
produces a large flow of saliva with a low protein concentration (Baum & Wellner, 
1999). In the present study, a large part of the protein secretion and protein 
synthesis depended on NO generation by the activity of neuronal type of NO-
synthase, which is also a common feature for β-adrenoceptor agonists and 
vasoactive intestinal peptide (Sayardoust & Ekström, 2003; 2004). In contrast, 
agonists of muscarinic receptors or α-adrenoceptors do not mobilize NO for 
protein secretion or protein synthesis (Sayardoust & Ekström, 2003; Ekstöm et 
al., 2007). The NO non-dependent responses are likely to be associated with 
cAMP, while the NO/cGMP-signalling system may mobilize calcium and or 
prolong the action of cAMP due to the inhibition of the enzymatic degradation of 
cAMP by phosphodiesterases (Imai et al., 1995; Looms et al., 2000; Tritsiaris et 
al., 2000). In the pancreas, the CCK-A receptor is associated with both the Ca2+ 
and the cAMP pathways to release zymogen granules (Williams, 2001). The 
intracellular signal-transduction events for CCK-B receptors, mainly studied in 
nervous tissue, are poorly characterized (Noble & Roques, 1999). This is also 
the case for the melatonin receptors where the studies are mainly on nervous 
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tissue. In many cases, melatonin inhibits the mobilization of various messengers, 
including cAMP, cGMP and Ca2+ (Vanecek, 1998). 
 
As would be expected inducible NO-synthase was activated in response to the 
intraductal injection of lipopolysaccharide in the parotid gland. Though, there 
seemed to be a role for neuronal type of NO-synthase of non-nervous origin in 
the inflammatory response, NO-generation by the activity of neuronal type of NO-
synthase in response to sympathetic activity or to cholecystokinin/gastrin and 
melatonin is not likely to induce inflammation. Activation of inflammatory cells 
and cytokine release are pre-requisites for triggering the inflammatory response 
(Morris & Billiar, 1994; Cloutier & McDonald, 2003). 
 
No doubt the relatively high doses of the hormone/hormone analogues tested in 
the anaesthetized animal did not mimic physiological conditions. Under natural 
conditions, gastrin, cholecystokinin and melatonin are likely to act in concert with 
the transmitters to regulate the glandular activites. In future experiments, it would 
be of interest to test the feeding responses of awake animals in the presence of 
the hormone receptor antagonists. Interestingly, in previous feeding experiments 
on the rat, a certain loss of glandular amylase activity and increase in protein 
synthesis occur in parasympathetically denervated parotid glands under 
muscarinic and α- and β-adrenoceptor blockade (Ekström et al., 1993; Ekström & 
Reinhold, 2001), implying a role for bloodborne substances such as the 
hormones (Liddle et al., 1984; Kitano et al., 2000). 
 
Proteomics applied to the saliva (Helmerhost & Oppenheim, 2007; Messana et 
al., 2008) will most likely reveal the secretion of a number of substances in 
response to gastrin, cholecystokinin and melatonin and, how these hormones 
may influence the processing of the secretory products. Stimulation of the 
salivary glands during the gastric and intestinal phases may add protective and 
healing substances to the saliva of benefit for the oral structures and (when 
swallowed) for the esophageus, the stomach and the intestines. This is 
exemplified by observations of Konturek and co-workers, showing pentagastrin   
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to increase the salivary levels of epidermal growth factor and, as a result, 
promoting ulcer healing (Konturek PC, 1996). Moreover, salivary gland products 
are not only delivered to the lumina but also to the circulation, implying an 
endocrine role for salivary glands (Isenman, Liebow & Rothman, 1999). Thus, it 
may be worth to consider the possibility that the hormones, in the present study 
may influence endocrine secretion from the glands. 
 
There is the possibility that changed blood levels of gastrin, cholecystokinin and 
melatonin, as consequence of diseases or drug treatments may influence the 
composition of saliva. Gastrinaemia occur under conditions such as Helicobacter 
pylori infections, gastrinoma (Zollinger-Ellison syndrome) and treatments with 
protone-pump inhibitors and histamine 2-receptor antagonists (removing the 
brake on gastrin release). In patients with Zollinger-Ellison syndrome, the output 
of epidermal growth factor is, in fact, elevated (Sarosiek et al., 2000). On the 
other hand, reduced blood levels of cholecystokinin have been reported in 
patients suffering from coeliac disease and diabetes (Berna & Jensen, 2007). 
Upon melatonin treatment of sleep disorders such as jet-lag and shift-work the 
blood level of melatonin increases (Bubenik, 2002). 
 
In our inflammation model, sCCK-8 and melatonin were found to be effective 
anti-inflammatory agents and their effect was reduced (sCCK-8) or unaffected 
(melatonin) by the receptor antagonists tested as judged by the myeloperoxidase 
activity. Both melatonin (Rice et al., 1995) and gastrin (Ingenito et al., 1986) 
appear in the saliva, and the amounts increase during a meal. And while focus 
has recently been on melatonin as a part of the defense of the oral cavity 
(Cutando et al., 2007a; Czesnikiewicz-Guzik et al., 2007), a role for 
cholecystokinin/ gastrin may also be at hand. Saliva contains particularly high 
concentrations of melatonin, about 25% of that in plasma (Laakso et al., 1990). 
Melatonin is highly lipophilic and may diffuse into intracellular compartments and 
exercise effects on nuclear binding sites independent of their effects on cell-
membrane receptors (Acuna-Catroviejo et al., 1994; Carlberg & Wiesseberg, 
1995). In the oral cavity, melatonin exerts antioxidative, immuno-modulatory and 
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anti-cancerogenic effects and further, promotes bone formation and growth by 
stimulating collagen fibers (Cutando et al., 2007a; Czesnikiewicz-Guzik et al., 
2007). Salivary melatonin may have important implications in the treatment of 
periodontal diseases, infections of the oral mucosa, wound healing following oral 
surgery, oral cancer and, as presently illustrated, gland inflammation (Gomez-
Moreno et al., 2007; Cutando et al., 2007a, b). 
 
Decreased volumes of saliva as well as changed saliva composition give rise to 
dry mouth. The quality of life of people suffering from dry mouth is dramatically 
impaired. The prevalence of dry mouth is 15-40%, and it is more common among 
women than men and it increases with age (Nederfors et al., 1997; Ship et al., 
2002). A new regulatory view of the functions of salivary glands and hormone-
exerted anti-inflammatory actions in the oral cavity may offer new possibities in 
the treatment of salivary dysfunctions. 
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